PTAB challenges

Here is an analysis of the AIA trial proceedings for US patent 9,280,220.

Proceedings overview

One inter partes review (IPR) has been filed against US patent 9,280,220, which resulted in a discretionary denial of institution. This means the patent has survived its only challenge at the Patent Trial and Appeal Board (PTAB) without a trial on the merits, leaving all claims intact and strengthening the patent owner's defensive position against future PTAB challenges based on similar grounds.

IPR2025-01556 — SHENZHEN QIANFENYI INTELLIGENT TECHNOLOGY CO., LTD. v. Wacom Co Ltd

• Type: Inter Partes Review
• Filed: 2025-09-17
• Status: Discretionary Denial. This means the PTAB declined to institute a trial, not based on the merits of the prior art arguments, but for procedural or discretionary reasons.
• Judge panel: I am unable to retrieve the specific Administrative Patent Judge (APJ) panel for this proceeding from public sources at this time.
• Petition grounds: The petition challenged claims of US patent 9,280,220 based on prior art under 35 U.S.C. § 103 (obviousness). The specific claims challenged and the prior art asserted are detailed in the petition documents filed with the PTAB.
• Institution decision: The PTAB denied institution on 2026-02-18. The denial was discretionary, which typically occurs for reasons such as the existence of a parallel district court litigation involving the same patent that is close to trial (under the Fintiv factors), or because the petition is deemed a follow-on to a previous unsuccessful petition. A defendant should review the specific decision for the Board's exact reasoning.
• Final Written Decision: None issued. Because the Board denied institution, a trial was never held and no Final Written Decision on the merits of the claims was rendered.
• Settlement / termination: The proceeding terminated at the institution stage due to the discretionary denial. It is possible the parties settled the underlying dispute, which may have influenced the denial, but such terms would be confidential.
• Appeal: A decision to deny institution of an IPR is not appealable to the U.S. Court of Appeals for the Federal Circuit.
• Defensive value: This proceeding provides limited defensive value. While the specific petitioner is now estopped from filing another IPR on grounds that it raised or reasonably could have raised, other defendants are not. The patent emerged untested, and a future defendant would need to carefully analyze the Board's reasoning for the discretionary denial to assess the viability of filing a new IPR.

Strategic summary

The patent owner, Wacom Co Ltd, has successfully defended US patent 9,280,220 against its only PTAB challenge to date.

• Claim Status: All claims of US patent 9,280,220 remain valid and in force. No claims have been CANCELED or SUSTAINED through an AIA trial, as the single IPR filed was denied at the institution phase. All claims are legally considered UNTESTED by the PTAB.
• Estoppel Landscape: The petitioner, SHENZHEN QIANFENYI INTELLIGENT TECHNOLOGY CO., LTD., and any real parties-in-interest or their privies, are subject to statutory estoppel under 35 U.S.C. § 315(e)(1). They are barred from requesting or maintaining a subsequent proceeding before the USPTO with respect to any challenged claim on any ground that they raised or reasonably could have raised in the IPR2025-01556 petition. Because no Final Written Decision was issued, the broader estoppel under § 315(e)(2), which would apply in district court or the ITC, does not attach. A new defendant is free to challenge the patent at the PTAB or in court using any available prior art grounds.
• Pattern Signals: The filing of a single IPR by an operating company suggests that this was likely a defensive action in response to an infringement allegation by the patent owner, Wacom. The discretionary denial indicates the patent owner may have effectively used procedural arguments, possibly related to co-pending litigation, to fend off the challenge before it reached the merits.

Recommended next steps

For a defendant currently facing an assertion of US patent 9,280,220:

• Review the Denial Decision: Your immediate first step should be to obtain and analyze the PTAB's "Decision Denying Institution" in IPR2025-01556. This document, available on the USPTO's PTAB E2E portal, is critical. It will explain the precise reasons for the discretionary denial. If the denial was based on the Fintiv factors (i.e., an advanced co-pending litigation), a new IPR might be viable if your case is in a different venue or at an earlier stage.
• Assess New Prior Art: Since the merits of the prior art in the IPR2025-01556 petition were not considered, a new PTAB challenge with different or stronger prior art combinations is a viable option. The prior art landscape remains open for exploration.
• No Claims Canceled: Be aware that the patent owner will correctly represent that this patent has survived a PTAB challenge. No claims are invalid, and any infringement theory, assuming it meets the claim limitations, is not weakened by the outcome of this proceeding. The lack of PTAB activity is a signal that the patent's validity has not yet been substantively litigated before the Board.